Cargando…
HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death
Hyperthermia has shown clinical potency as a single agent or as adjuvant to other therapies in cancer treatment. However, thermotolerance induced by thermosensitive genes such as the heat shock proteins can limit the efficacy of hyperthermic treatment. In the present study, we identified HSPB1 (HSP2...
Autores principales: | Wang, He-Xiao, Yang, Yang, Guo, Hao, Hou, Dian-Dong, Zheng, Song, Hong, Yu-Xiao, Cai, Yun-Fei, Huo, Wei, Qi, Rui-Qun, Zhang, Li, Chen, Hong-Duo, Gao, Xing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341888/ https://www.ncbi.nlm.nih.gov/pubmed/27626679 http://dx.doi.org/10.18632/oncotarget.11894 |
Ejemplares similares
-
Hyperthermia promotes M1 polarization of macrophages via exosome-mediated HSPB8 transfer in triple negative breast cancer
por: Xu, Di, et al.
Publicado: (2023) -
HSPB1 as a Novel Regulator of Ferroptotic Cancer Cell Death
por: Sun, Xiaofang, et al.
Publicado: (2015) -
DnaJA4 is involved in responses to hyperthermia by regulating the expression of F-actin in HaCaT cells
por: Liu, Rui-Jiao, et al.
Publicado: (2021) -
HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes
por: Ke, Lei, et al.
Publicado: (2011) -
Human HspB1, HspB3, HspB5 and HspB8: Shaping these disease factors during vertebrate evolution
por: Benndorf, Rainer, et al.
Publicado: (2022)